Sentence examples for business model development from inspiring English sources
Then the coaches joined their teams for three days of business model development, feedback, and training.
Other topics that will be discussed include FDA regulation of medical technology, intellectual property, value proposition, and business model development.
Our research informs decisions about product, program, and business model development, as well as the design of regulatory solutions that protect consumers.
The new approach facilitates, e.g., business scalability and risk avoidance and clarifies the interplay between classical business model development and strategic sustainability thinking.
This paper provides an exploratory study of how rewards-based crowdfunding affects business model development for music industry artists, labels and live sector companies.
MIT SMR coauthors Clayton Christensen and Derek van Bever discussed their recent article, "The Hard Truth About Business Model Innovation". They explained how understanding the stages of business model development is crucial to creating a successful process for repeated innovation.
Over the past year, a team of Yale students, faculty, and staff across the University has been working on developing the program, including an online curriculum tailored to working professionals, video production, online content development, online education business models development, cultivating new marketing and sales channels, setting up the administrative infrastructure and more.
The processes used to organize and implement the search for the business model areCustomer Development and Agile Development.
When someone is leading a startup, it's tempting to focus primarily on the business model, customer development, or product-market fit.
Through the Startup Studio in the spring semester, we got the opportunity to work on our idea – prototyping, creating a business model, customer development and how to pitch our idea to a large audience.
Biogen CEO Dr. George A. Scangos '70 presents an overview of the company's business model, drug development and strategy for future innovation, as well as a discussion of pricing and financial returns for biotechnology companies and the expectations of patients, physicians, investors and politicians.
